by McKesson Ventures | Dec 8, 2021 | Press Releases
Be The Match BioTherapies® and Vineti announced a collaboration to create streamlined solutions that alleviate supply chain management difficulties related to cell and gene therapies. The collaboration is non-exclusive and is expected to unite the industry’s top...
by McKesson Ventures | Oct 19, 2021 | Press Releases
Autolomous, a developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of digital enterprise platforms for cell and gene therapy supply chains, have announced a non-exclusive, collaborative partnership. The...
by McKesson Ventures | Oct 12, 2021 | Press Releases
Körber, a manufacturing execution systems supplier for pharma and biotech, has partnered with Vineti to integrate Körber’s Werum PAS-X-MES with Vineti’s Personalized Therapy Management (PTM) platform. The partnership will empower biopharma customers with an integrated...
by McKesson Ventures | Jul 23, 2021 | Media Coverage
While there are more startups than ever, there’s also more money chasing them than ever. Vator News is profiling key members of the investment community to help companies understand what investors are looking for and how they can help startups to scale. In this...
by McKesson Ventures | Oct 17, 2020 | Portfolio News
Vineti, a cloud software startup that manages the development of drugs such as cancer vaccines and cell and gene therapies recently raised a $33 million extension to its Series C round. Business Insider recently interviewed Vineti CEO and Co-founder Amy DuRoss about...
